Company profile: Life Genomics
1.1 - Company Overview
Company description
- Provider of genetic testing services for healthcare and the public; founded in 2014 as a spin-off from TATAA Biocenter, operating a shared laboratory with TATAA, one of Europe’s premier, with backing including government ALMI Invest.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Life Genomics
BostonGene
HQ: United States
Website
- Description: Provider of AI-powered molecular and immune profiling and a cloud-based platform for personalized cancer therapy analysis; multiplex immunofluorescence (MxIF) pipeline analyzing tissue architecture and cell interactions, detecting up to 40 protein markers; bioinformatics services using multi-omics databases and proprietary software; biopharma solutions and target analysis to evaluate drug candidates in a certified environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BostonGene company profile →
Signal Genetics
HQ: United States
Website
- Description: Provider of innovative molecular diagnostic services that help physicians make better-informed decisions in the care of patients with cancer; a commercial-stage molecular diagnostics company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Signal Genetics company profile →
RootPath
HQ: United States
Website
- Description: Provider of a personalized T cell therapy platform and gene synthesis solutions, including PathFinder DNA Assembly™ for accurate long-gene construction, Molecular Toothpick™ for error screening and recovery, PathFinder Custom Gene Library™ with sequence-verified plasmids, genes and fragments at scale (300 bp–10 kb), mutagenesis and variant libraries, and recombinant antibodies with CHO-cell expression and characterization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RootPath company profile →
Singular Bio
HQ: United States
Website
- Description: Provider of single molecule detection technology enabling single-molecule analysis of a patient's DNA with high sensitivity for detecting many common conditions, aimed at expanding access to fundamental healthcare information by making advanced genetic tests available to everyone.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Singular Bio company profile →
Gnubio
HQ: United States
Website
- Description: Provider of scalable desktop DNA sequencing systems for diagnostic and applied markets, integrating target selection, DNA amplification, sequencing, and analysis via emulsion-based droplet microfluidics. Offers single-use consumable cartridges and workflows for targeted sequencing and hotspot analysis, with whole genome and transcriptome applications in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gnubio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Life Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Life Genomics
2.2 - Growth funds investing in similar companies to Life Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Life Genomics
4.2 - Public trading comparable groups for Life Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →